Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Zoledronic acid

EU orphan designation number: EU/3/13/1192   
Active ingredient: Zoledronic acid
Indication: Treatment of complex regional pain syndrome
Sponsor: Axsome Therapeutics Limited
88 Wood Street, London EC2V 7RS, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
9/10/2013 Orphan designation EMA/OD/088/13 (2013)6737 of 7/10/2013